For further exploration of the possible involvements of EZH2 and DNMT3a in regulating miR-340-5p, miR-145-5p, and miR-143-3p expression, we next inhibited EZH2 and DNMT3a activity in prostate cancer cells using specific inhibitors and gene knockdown technology. This evidence concerns the gene DNMT3A and prostate carcinoma.